Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UB-221 as an Add-on Therapy in CSU Patients
Clinical trial NCT03632291 · COMPLETED
Trial details
- NCT number
- NCT03632291
- Sponsor
- United BioPharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-09
- Primary completion
- 2021-01-19
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.